Tham khảo Lapaquistat

  1. Greenwood J, Steinman L, Zamvil SS (tháng 5 năm 2006). “Statin therapy and autoimmune disease: from protein prenylation to immunomodulation”. Nat. Rev. Immunol. 6 (5): 358–70. doi:10.1038/nri1839. PMC 3842637. PMID 16639429.
  2. Takeda Pharmaceutical Company Limited press release - Discontinuation of Development of TAK-475, A Compound for Treatment of Hypercholesterolemia
  3. Stein, Evan (ngày 25 tháng 4 năm 2011). “Lapaquistat Acetate, Development of a Squalene Synthase Inhibitor for the Treatment of Hypercholesterolemia”. Circulation. 123 (18): 1974–1985. doi:10.1161/CIRCULATIONAHA.110.975284. PMID 21518985. Đã bỏ qua tham số không rõ |displayauthors= (gợi ý |display-authors=) (trợ giúp)
  4. Nagashima S; Yagyu H; Tozawa R; Tazoe F; Takahashi M; Kitamine T (2015). “Plasma cholesterol-lowering and transient liver dysfunction in mice lacking squalene synthase in the liver”. J Lipid Res. 56 (5): 998–1005. doi:10.1194/jlr.M057406. PMC 4409289. PMID 25755092. Đã bỏ qua tham số không rõ |displayauthors= (gợi ý |display-authors=) (trợ giúp)
  5. Wasko BM, Smits JP, Shull LW, Wiemer DF, Hohl RJ (2011). “A novel bisphosphonate inhibitor of squalene synthase combined with a statin or a nitrogenous bisphosphonate in vitro”. J Lipid Res. 52 (11): 1957–64. doi:10.1194/jlr.M016089. PMC 3196227. PMID 21903868.